These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15350536)

  • 1. Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts.
    Ramoni C; Spadaro F; Barletta B; Dupuis ML; Podo F
    Exp Cell Res; 2004 Oct; 299(2):370-82. PubMed ID: 15350536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
    Spadaro F; Ramoni C; Mezzanzanica D; Miotti S; Alberti P; Cecchetti S; Iorio E; Dolo V; Canevari S; Podo F
    Cancer Res; 2008 Aug; 68(16):6541-9. PubMed ID: 18701477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts.
    van Dijk MC; Muriana FJ; de Widt J; Hilkmann H; van Blitterswijk WJ
    J Biol Chem; 1997 Apr; 272(17):11011-6. PubMed ID: 9110992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells.
    Ramoni C; Spadaro F; Menegon M; Podo F
    J Immunol; 2001 Sep; 167(5):2642-50. PubMed ID: 11509606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
    Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
    Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
    Kiss Z; Tomono M
    Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.
    Podo F; Ferretti A; Knijn A; Zhang P; Ramoni C; Barletta B; Pini C; Baccarini S; Pulciani S
    Anticancer Res; 1996; 16(3B):1399-412. PubMed ID: 8694508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.
    Zhang L; Li HY; Li H; Zhao J; Su L; Zhang Y; Zhang SL; Miao JY
    J Cell Physiol; 2011 Jun; 226(6):1694-701. PubMed ID: 21413027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
    Amtmann E
    Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
    Girón-Calle J; Srivatsa K; Forman HJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
    Cecchetti S; Bortolomai I; Ferri R; Mercurio L; Canevari S; Podo F; Miotti S; Iorio E
    PLoS One; 2015; 10(9):e0136120. PubMed ID: 26402860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
    Larsen EC; Hatcher JF; Adibhatla RM
    Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis.
    Zhang L; Zhao J; Su L; Huang B; Wang L; Su H; Zhang Y; Zhang S; Miao J
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):411-8. PubMed ID: 20139365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
    Adibhatla RM; Hatcher JF; Gusain A
    Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylcholine-specific phospholipase C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cells.
    Zhao J; Zhao B; Wang W; Huang B; Zhang S; Miao J
    J Cell Biochem; 2007 Oct; 102(2):421-8. PubMed ID: 17393430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKC alpha depletion in RAW264.7 macrophages following microbial/IFNgamma stimulation is PC-PLC-mediated.
    von Knethen A; Brüne B
    Antioxid Redox Signal; 2005; 7(9-10):1217-22. PubMed ID: 16115026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. fMLP-induced arachidonic acid release in db-cAMP-differentiated HL-60 cells is independent of phosphatidylinositol-4, 5-bisphosphate-specific phospholipase C activation and cytosolic phospholipase A(2) activation.
    Sternfeld L; Thévenod F; Schulz I
    Arch Biochem Biophys; 2000 Jun; 378(2):246-58. PubMed ID: 10860542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells.
    Mercurio L; Cecchetti S; Ricci A; Pacella A; Cigliana G; Bozzuto G; Podo F; Iorio E; Carpinelli G
    PLoS One; 2017; 12(4):e0176108. PubMed ID: 28423060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Singh AT; Radeff JM; Kunnel JG; Stern PH
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.
    Walter M; Reinecke H; Gerdes U; Nofer JR; Höbbel G; Seedorf U; Assmann G
    J Clin Invest; 1996 Nov; 98(10):2315-23. PubMed ID: 8941649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.